Kimberley I Hemelrijk
Overview
Explore the profile of Kimberley I Hemelrijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Nieuwkerk A, Hemelrijk K, Aarts H, Leeuwis A, Majoie C, Daemen M, et al.
EClinicalMedicine
. 2025 Mar;
81:103092.
PMID: 40026830
Background: Approximately one-third of patients with symptomatic severe aortic valve stenosis scheduled for transcatheter aortic valve implantation (TAVI) have some degree of cognitive impairment. The effect of TAVI on cardiac...
2.
Aarts H, van Nieuwkerk A, Hemelrijk K, Salgado Fernandez J, Tchetche D, de Brito Jr F, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(1):89-99.
PMID: 39814498
Background: Transcatheter aortic valve replacement (TAVR) harbors the risk of periprocedural complications that require emergent cardiac surgery, or "surgical bailout." Surgical bailout intends to be lifesaving but is associated with...
3.
Aarts H, Hemelrijk K, Broeze G, van Ginkel D, Versteeg G, Overduin D, et al.
Am Heart J
. 2024 Dec;
281:133-139.
PMID: 39674524
Background: Concomitant coronary artery disease (CAD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). The optimal treatment strategy for CAD is a topic...
4.
Versteeg G, Rooijakkers M, Hemelrijk K, Vlaar P, Overduin D, van Wely M, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2438578.
PMID: 39412806
Importance: An upper-extremity approach for secondary access during transfemoral transcatheter aortic valve implantation (TAVI) may reduce clinically relevant secondary access site-related bleeding. Objective: To investigate the safety and efficacy of...
5.
van Nieuwkerk A, Aarts H, Hemelrijk K, Urbano Carrillo C, Tchetche D, de Brito Jr F, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e032901.
PMID: 39190595
Background: Cerebrovascular events remain one of the most devastating complications of transcatheter aortic valve implantation (TAVI). Data from real-world contemporary cohorts on longitudinal trends and outcomes remain limited. The aim...
6.
Rooijakkers M, Versteeg G, Hemelrijk K, Aarts H, Overduin D, van Ginkel D, et al.
Neth Heart J
. 2024 Apr;
32(7-8):270-275.
PMID: 38653922
Background: During transcatheter aortic valve implantation (TAVI), secondary access is required for angiographic guidance and temporary pacing. The most commonly used secondary access sites are the femoral artery (angiographic guidance)...
7.
van Nieuwkerk A, Aarts H, Hemelrijk K, Canton T, Tchetche D, de Brito Jr F, et al.
JACC Cardiovasc Interv
. 2023 Dec;
16(24):2951-2962.
PMID: 38151309
Background: Bleeding is one of the most frequent complications in patients undergoing transcatheter aortic valve replacement (TAVR). Importantly, major bleeding is associated with poor clinical outcomes after TAVR. However, large...
8.
van Nieuwkerk A, Hemelrijk K, Bron E, Leeuwis A, Majoie C, Daemen M, et al.
Neth Heart J
. 2023 Nov;
31(12):461-470.
PMID: 37910335
Background: Approximately one-third of patients with symptomatic severe aortic valve stenosis who are scheduled for transcatheter aortic valve implantation (TAVI) have some degree of cognitive impairment. TAVI may have negative...